JP2008500399A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008500399A5 JP2008500399A5 JP2007527564A JP2007527564A JP2008500399A5 JP 2008500399 A5 JP2008500399 A5 JP 2008500399A5 JP 2007527564 A JP2007527564 A JP 2007527564A JP 2007527564 A JP2007527564 A JP 2007527564A JP 2008500399 A5 JP2008500399 A5 JP 2008500399A5
- Authority
- JP
- Japan
- Prior art keywords
- immunogenic composition
- protein
- nucleic acid
- heterologous nucleic
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57343304P | 2004-05-21 | 2004-05-21 | |
| US60/573,433 | 2004-05-21 | ||
| US64373705P | 2005-01-12 | 2005-01-12 | |
| US60/643,737 | 2005-01-12 | ||
| PCT/US2005/018225 WO2006078294A2 (en) | 2004-05-21 | 2005-05-20 | Alphavirus vectors for respiratory pathogen vaccines |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008125258A Division JP2008266341A (ja) | 2004-05-21 | 2008-05-12 | 呼吸器系病原体ワクチンのためのアルファウイルスベクター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008500399A JP2008500399A (ja) | 2008-01-10 |
| JP2008500399A5 true JP2008500399A5 (enExample) | 2008-06-26 |
| JP4896021B2 JP4896021B2 (ja) | 2012-03-14 |
Family
ID=36692669
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007527564A Expired - Lifetime JP4896021B2 (ja) | 2004-05-21 | 2005-05-20 | 呼吸器系病原体ワクチンのためのアルファウイルスベクター |
| JP2008125258A Pending JP2008266341A (ja) | 2004-05-21 | 2008-05-12 | 呼吸器系病原体ワクチンのためのアルファウイルスベクター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008125258A Pending JP2008266341A (ja) | 2004-05-21 | 2008-05-12 | 呼吸器系病原体ワクチンのためのアルファウイルスベクター |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US20090104226A1 (enExample) |
| EP (3) | EP2848692B1 (enExample) |
| JP (2) | JP4896021B2 (enExample) |
| CA (1) | CA2567446C (enExample) |
| ES (1) | ES2647491T3 (enExample) |
| WO (1) | WO2006078294A2 (enExample) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2526196T3 (es) | 2004-05-25 | 2015-01-08 | Novartis Vaccines And Diagnostics, Inc. | Constructos de encapsidación de replicones de alfavirus |
| FI4005592T3 (fi) | 2010-07-06 | 2023-01-13 | Virionin kaltaisia kuljetuspartikkeleita itsereplikoituville rna-molekyyleille | |
| US9770463B2 (en) | 2010-07-06 | 2017-09-26 | Glaxosmithkline Biologicals Sa | Delivery of RNA to different cell types |
| PL2591114T3 (pl) | 2010-07-06 | 2017-08-31 | Glaxosmithkline Biologicals Sa | Immunizacja dużych ssaków małymi dawkami rna |
| AU2011276234B2 (en) | 2010-07-06 | 2016-02-25 | Glaxosmithkline Biologicals S.A. | Liposomes with lipids having an advantageous pKa- value for RNA delivery |
| PT3243526T (pt) | 2010-07-06 | 2020-03-04 | Glaxosmithkline Biologicals Sa | Distribuição de arn para despoletar múltiplas vias imunitárias |
| PT3981427T (pt) | 2010-08-31 | 2022-06-27 | Glaxosmithkline Biologicals Sa | Lipossomas peguilados para entrega de arn codificador de imunogénio |
| PL4008357T3 (pl) | 2010-08-31 | 2023-03-06 | Glaxosmithkline Biologicals Sa | Małe liposomy do dostarczania rna kodującego immunogen |
| TR201903651T4 (tr) | 2010-10-11 | 2019-04-22 | Glaxosmithkline Biologicals Sa | Antijen uygulama platformları. |
| WO2012116714A1 (en) | 2011-03-02 | 2012-09-07 | Curevac Gmbh | Vaccination in elderly patients |
| CA2837145A1 (en) * | 2011-05-26 | 2012-11-29 | Glaxosmithkline Biologicals Sa | Inactivated dengue virus vaccine |
| CN103748078B (zh) | 2011-06-08 | 2016-11-09 | 夏尔人类遗传性治疗公司 | 可裂解脂质 |
| CA3107288A1 (en) | 2011-06-08 | 2012-12-13 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for mrna delivery |
| CN103764121A (zh) | 2011-07-06 | 2014-04-30 | 诺华股份有限公司 | 用于递送rna分子的具有有用n:p比的脂质体 |
| EP2729165B1 (en) | 2011-07-06 | 2017-11-08 | GlaxoSmithKline Biologicals SA | Immunogenic combination compositions and uses thereof |
| BR112014004607A2 (pt) * | 2011-08-31 | 2017-03-21 | Novartis Ag | lipossomas peguilados para entrega de rna codificado imunogênico |
| EP2768530A1 (en) * | 2011-10-11 | 2014-08-27 | Novartis AG | Recombinant self-replicating polycistronic rna molecules |
| EP2793939A1 (en) * | 2011-12-23 | 2014-10-29 | Novartis AG | Stable compositions for immunising against staphylococcus aureus |
| WO2014027084A1 (en) | 2012-08-17 | 2014-02-20 | Intervet International B.V. | An immunogenic composition of killed leptospira bacteria |
| EP2895191B1 (en) | 2012-09-14 | 2019-06-05 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Brachyury protein, adenoviral vectors encoding brachyury protein, and their use |
| MX384992B (es) | 2014-06-13 | 2025-03-14 | Glaxosmithkline Biologicals Sa | Combinaciones inmunógenas. |
| KR102535670B1 (ko) | 2015-06-12 | 2023-05-22 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 아데노바이러스 폴리뉴클레오티드 및 폴리펩티드 |
| JP7048482B2 (ja) | 2015-08-03 | 2022-04-05 | アメリカ合衆国 | Ｂｒａｃｈｙｕｒｙ欠失変異体、Ｂｒａｃｈｙｕｒｙ欠失変異体をコードする非酵母ベクター、及びそれらの使用 |
| JP2019511255A (ja) | 2016-01-11 | 2019-04-25 | バーンダリ，インク． | マイクロニードル組成物およびそれを使用する方法 |
| WO2017162265A1 (en) * | 2016-03-21 | 2017-09-28 | Biontech Rna Pharmaceuticals Gmbh | Trans-replicating rna |
| MA50335A (fr) * | 2016-12-08 | 2020-08-19 | Modernatx Inc | Vaccins à acide nucléique contre des virus respiratoires |
| EP3580227A4 (en) | 2017-02-07 | 2020-09-16 | Agency For Science, Technology And Research | NSP ALPHAVIRUS MUTANTS USED AS VACCINES |
| SG11201910101SA (en) | 2017-05-08 | 2019-11-28 | Gritstone Oncology Inc | Alphavirus neoantigen vectors |
| CN118976103A (zh) * | 2017-12-18 | 2024-11-19 | 英特维特国际股份有限公司 | 猪甲型流感病毒疫苗 |
| AU2018392884B2 (en) | 2017-12-20 | 2021-11-11 | Glaxosmithkline Biologicals Sa | Epstein-Barr Virus antigen constructs |
| US12239699B2 (en) | 2018-09-11 | 2025-03-04 | Shanghai Public Health Clinical Center | Immunogen for broad-spectrum influenza vaccine and application thereof |
| JP2022512625A (ja) * | 2018-10-08 | 2022-02-07 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | 生物学的製剤の投与のためのアルファウイルスベースのレプリコン |
| CA3119752A1 (en) * | 2018-11-07 | 2020-05-14 | Gritstone Oncology, Inc. | Alphavirus neoantigen vectors and interferon inhibitors |
| NL2022538B1 (en) | 2019-02-08 | 2020-08-19 | Academisch Ziekenhuis Groningen | Methods for providing purified viral particles of Semliki Forest Virus (SFV), preparations obtainable thereby, and uses thereof. |
| CN114072516B (zh) | 2019-05-30 | 2025-01-14 | 磨石生物公司 | 经修饰的腺病毒 |
| US12194089B2 (en) | 2020-02-04 | 2025-01-14 | CureVac SE | Coronavirus vaccine |
| WO2021183564A1 (en) | 2020-03-09 | 2021-09-16 | Arcturus Therapeutics, Inc. | Compositions and methods for inducing immune responses |
| IT202000009625A1 (it) * | 2020-04-30 | 2021-10-30 | Takis S R L | Polinucleotidi codificanti antigeni di sars-cov-2 e relativo uso in campo medico come vaccini. |
| US20230355741A1 (en) | 2020-05-11 | 2023-11-09 | Intervet Inc. | Feline Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine |
| CA3170740A1 (en) * | 2020-05-29 | 2021-12-02 | Curevac Ag | Nucleic acid based combination vaccines |
| BR112022025678A2 (pt) * | 2020-06-19 | 2023-01-17 | Intervet Int Bv | Vacina contra o vírus da influenza a suína compreendendo duas partículas de replicon de rna distintas |
| CN115768785A (zh) * | 2020-06-19 | 2023-03-07 | 英特维特国际股份有限公司 | 包含含有编码病毒的不同神经氨酸酶抗原的第一、第二和第三核酸序列的核酸构建体的甲型猪流感病毒疫苗 |
| JP2023541108A (ja) | 2020-08-06 | 2023-09-28 | グリットストーン バイオ インコーポレイテッド | マルチエピトープワクチンカセット |
| JP2023537609A (ja) | 2020-08-14 | 2023-09-04 | アークトゥラス・セラピューティクス・インコーポレイテッド | 脂質ナノ粒子を凍結乾燥する方法 |
| EP4210740A1 (en) * | 2020-09-07 | 2023-07-19 | Intervet International B.V. | Ha stem vaccine for ha antibody-positive targets |
| WO2022087006A1 (en) * | 2020-10-20 | 2022-04-28 | George Mason Research Foundation, Inc. | Hybrid alphavirus-sars-cov-2 particle and methodology of making and using same |
| US20240000920A1 (en) | 2020-11-12 | 2024-01-04 | Intervet Inc. | Recombinant vectors encoding chimeric coronavirus spike proteins and use thereof |
| IL303315A (en) * | 2020-12-02 | 2023-07-01 | Seqirus Inc | Multicistronic RNA components and their uses |
| KR20230164648A (ko) | 2020-12-22 | 2023-12-04 | 큐어백 에스이 | SARS-CoV-2 변이체에 대한 RNA 백신 |
| CA3205216A1 (en) * | 2021-01-19 | 2022-07-28 | Sue-Jean HONG | Modified alphavirus vectors |
| CN112899301B (zh) * | 2021-01-29 | 2023-04-11 | 中国热带农业科学院热带生物技术研究所 | 一种木薯普通花叶病毒诱导的基因沉默系统及其应用 |
| WO2022165340A2 (en) * | 2021-02-01 | 2022-08-04 | Aegle Biotech | Universal vaccines against immunogens of pathogenic organisms that provide organism-specific and cross-group protection |
| US20220401548A1 (en) * | 2021-06-17 | 2022-12-22 | National Yang Ming Chiao Tung University | Sindbis virus dna-based vaccine |
| WO2023113016A1 (en) * | 2021-12-17 | 2023-06-22 | Vlp Therapeutics Japan, Inc. | Efficient vaccine |
| DE202023106198U1 (de) | 2022-10-28 | 2024-03-21 | CureVac SE | Impfstoff auf Nukleinsäurebasis |
Family Cites Families (82)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5360897A (en) | 1981-08-31 | 1994-11-01 | The University Of Rochester | Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad |
| SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
| CA1247080A (en) | 1983-03-08 | 1988-12-20 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
| IL73534A (en) | 1983-11-18 | 1990-12-23 | Riker Laboratories Inc | 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds |
| US5916588A (en) | 1984-04-12 | 1999-06-29 | The Liposome Company, Inc. | Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use |
| US6090406A (en) | 1984-04-12 | 2000-07-18 | The Liposome Company, Inc. | Potentiation of immune responses with liposomal adjuvants |
| US5091309A (en) | 1986-01-16 | 1992-02-25 | Washington University | Sindbis virus vectors |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| AU631377B2 (en) | 1988-08-25 | 1992-11-26 | Liposome Company, Inc., The | Affinity associated vaccine |
| US5238944A (en) | 1988-12-15 | 1993-08-24 | Riker Laboratories, Inc. | Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine |
| US4929624A (en) | 1989-03-23 | 1990-05-29 | Minnesota Mining And Manufacturing Company | Olefinic 1H-imidazo(4,5-c)quinolin-4-amines |
| CA2017507C (en) | 1989-05-25 | 1996-11-12 | Gary Van Nest | Adjuvant formulation comprising a submicron oil droplet emulsion |
| US5389640A (en) | 1991-03-01 | 1995-02-14 | Minnesota Mining And Manufacturing Company | 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines |
| US5268376A (en) | 1991-09-04 | 1993-12-07 | Minnesota Mining And Manufacturing Company | 1-substituted 1H-imidazo[4,5-c]quinolin-4-amines |
| US5266575A (en) | 1991-11-06 | 1993-11-30 | Minnesota Mining And Manufacturing Company | 2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines |
| US5340740A (en) | 1992-05-15 | 1994-08-23 | North Carolina State University | Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process |
| EP0671948B1 (en) | 1992-06-25 | 1997-08-13 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Vaccine composition containing adjuvants |
| US5395937A (en) | 1993-01-29 | 1995-03-07 | Minnesota Mining And Manufacturing Company | Process for preparing quinoline amines |
| ES2109685T5 (es) | 1993-03-23 | 2005-09-01 | Smithkline Beecham Biologicals S.A. | Composiciones para vacunas que contienen monofosforil-lipido a 3-o-desacilado. |
| ATE195735T1 (de) | 1993-07-15 | 2000-09-15 | Minnesota Mining & Mfg | Imidazo (4,5-c)pyridin-4-amine |
| US5352784A (en) | 1993-07-15 | 1994-10-04 | Minnesota Mining And Manufacturing Company | Fused cycloalkylimidazopyridines |
| US6015686A (en) | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
| CA2158937C (en) | 1993-09-15 | 2006-01-03 | Thomas W. Dubensky, Jr. | Recombinant alphavirus vectors |
| GB9326174D0 (en) | 1993-12-22 | 1994-02-23 | Biocine Sclavo | Mucosal adjuvant |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
| FR2726003B1 (fr) | 1994-10-21 | 2002-10-18 | Agronomique Inst Nat Rech | Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires |
| US5482936A (en) | 1995-01-12 | 1996-01-09 | Minnesota Mining And Manufacturing Company | Imidazo[4,5-C]quinoline amines |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| US5792462A (en) * | 1995-05-23 | 1998-08-11 | University Of North Carolina At Chapel Hill | Alphavirus RNA replicon systems |
| GB9513261D0 (en) | 1995-06-29 | 1995-09-06 | Smithkline Beecham Biolog | Vaccines |
| FR2737730B1 (fr) | 1995-08-10 | 1997-09-05 | Pasteur Merieux Serums Vacc | Procede de purification de virus par chromatographie |
| DE19612967A1 (de) | 1996-04-01 | 1997-10-02 | Behringwerke Ag | Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren |
| US6451592B1 (en) | 1996-04-05 | 2002-09-17 | Chiron Corporation | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| ES2301178T3 (es) | 1996-04-05 | 2008-06-16 | Novartis Vaccines & Diagnostic | Vectores basados en alfavirus recombinantes con inhibicion reducida de la sintesis macromolecular celular. |
| US5842723A (en) | 1996-11-25 | 1998-12-01 | Burex Automotive America, Inc. | Flexible connection arrangement for connecting a pipe of an exhaust system to an engine, especially in a motor vehicle |
| US5811407A (en) * | 1997-02-19 | 1998-09-22 | The University Of North Carolina At Chapel Hill | System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| EP2172216A3 (en) | 1997-03-10 | 2010-11-24 | Ottawa Hospital Research Institute | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| US6818222B1 (en) | 1997-03-21 | 2004-11-16 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
| GB9712347D0 (en) | 1997-06-14 | 1997-08-13 | Smithkline Beecham Biolog | Vaccine |
| US6060308A (en) | 1997-09-04 | 2000-05-09 | Connaught Laboratories Limited | RNA respiratory syncytial virus vaccines |
| DE69838992T2 (de) | 1997-09-05 | 2008-12-24 | Glaxosmithkline Biologicals S.A., Rixensart | Öl-in-Wasser Emulsionen mit Saponinen |
| WO1999025858A1 (en) | 1997-11-14 | 1999-05-27 | Connaught Laboratories Limited | Alphavirus vectors for paramyxovirus vaccines |
| GB9725084D0 (en) | 1997-11-28 | 1998-01-28 | Medeva Europ Ltd | Vaccine compositions |
| WO1999052549A1 (en) | 1998-04-09 | 1999-10-21 | Smithkline Beecham Biologicals S.A. | Adjuvant compositions |
| US6562798B1 (en) | 1998-06-05 | 2003-05-13 | Dynavax Technologies Corp. | Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
| GB9817052D0 (en) | 1998-08-05 | 1998-09-30 | Smithkline Beecham Biolog | Vaccine |
| WO2000018929A2 (en) * | 1998-09-25 | 2000-04-06 | Smithkline Beecham Biologicals S.A. | Paramyxovirus vaccines |
| DK1126876T3 (da) | 1998-10-16 | 2007-07-02 | Glaxosmithkline Biolog Sa | Adjuvanssystemer og vacciner |
| WO2000039318A1 (en) | 1998-12-31 | 2000-07-06 | Chiron Corporation | Compositions and methods for packaging of alphavirus vectors |
| US6329201B1 (en) | 1998-12-31 | 2001-12-11 | Chiron Corporation | Compositions and methods for packaging of alphavirus vectors |
| AU4366000A (en) | 1999-04-14 | 2000-11-14 | Chiron Corporation | Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| US6492169B1 (en) | 1999-05-18 | 2002-12-10 | Crucell Holland, B.V. | Complementing cell lines |
| EP1221971A2 (en) | 1999-09-24 | 2002-07-17 | SmithKline Beecham Biologics SA | Use of the combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines |
| CA2383110A1 (en) | 1999-09-24 | 2001-03-29 | Veronique Henderickx | Adjuvant comprising a polyoxyethylene alkyl ether or ester and at least one non-ionic surfactant |
| EP1103610A1 (en) | 1999-11-26 | 2001-05-30 | Introgene B.V. | Production of vaccines from immortalised mammalian cell lines |
| US20010044416A1 (en) | 2000-01-20 | 2001-11-22 | Mccluskie Michael J. | Immunostimulatory nucleic acids for inducing a Th2 immune response |
| AU2001249380A1 (en) * | 2000-03-22 | 2001-11-07 | Chiron Corporation | Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| AU2001259211B2 (en) * | 2000-04-28 | 2006-07-13 | St. Jude Children's Research Hospital | DNA transfection system for the generation of infectious influenza virus |
| CA2410948C (en) | 2000-05-31 | 2012-07-17 | Chiron Corporation | Method for the purification of alphavirus replicon particles |
| ES2295175T3 (es) * | 2000-06-23 | 2008-04-16 | Wyeth Holdings Corporation | Ensamblaje de particulas similares al virus (vlp) de la gripe de tipo salvaje y quimericas. |
| CA2423487C (en) | 2000-09-26 | 2015-12-15 | Hybridon, Inc. | Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| KR20020059856A (ko) * | 2001-01-08 | 2002-07-16 | 김철중 | 에이치아이브이 유사입자의 제조 |
| WO2002080982A2 (en) * | 2001-01-12 | 2002-10-17 | Chiron Corporation | Nucleic acid mucosal immunization |
| EP2332573A1 (en) * | 2001-05-31 | 2011-06-15 | Novartis Vaccines and Diagnostics, Inc. | Chimeric alphavirus replicon particles |
| WO2003023026A1 (en) | 2001-09-06 | 2003-03-20 | Alphavax, Inc. | Alphavirus replicon vector systems |
| EP2196217A1 (en) | 2001-09-14 | 2010-06-16 | Cytos Biotechnology AG | Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| CA2492823A1 (en) | 2001-09-14 | 2003-03-27 | Martin F. Bachmann | In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles |
| WO2003035836A2 (en) | 2001-10-24 | 2003-05-01 | Hybridon Inc. | Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| FR2832423B1 (fr) | 2001-11-22 | 2004-10-08 | Vivalis | Systeme d'expression de proteines exogenes dans un systeme aviaire |
| FR2836924B1 (fr) | 2002-03-08 | 2005-01-14 | Vivalis | Lignees de cellules aviaires utiles pour la production de substances d'interet |
| AU2003267971A1 (en) * | 2002-06-21 | 2004-01-06 | Alphavax, Inc. | Improved alphavirus vectors having attenuated virion structural proteins |
| WO2004055166A2 (en) * | 2002-12-13 | 2004-07-01 | Alphavax, Inc. | Multi-antigenic alphavirus replicon particles and methods |
| WO2004060308A2 (en) | 2002-12-27 | 2004-07-22 | Chiron Corporation | Thiosemicarbazones as anti-virals and immunopotentiators |
| WO2004064759A2 (en) | 2003-01-21 | 2004-08-05 | Chiron Corporation | Use of tryptanthrin compounds for immune potentiation |
| EP1608762B1 (en) * | 2003-03-20 | 2014-01-08 | Alphavax, Inc. | Improved alphavirus replicons and helper constructs |
| CA2522379C (en) | 2003-04-10 | 2012-10-23 | Chiron Corporation | The severe acute respiratory syndrome coronavirus |
| WO2005016961A1 (en) * | 2003-06-05 | 2005-02-24 | Wyeth Holdings Corporation | Immunogenic compositions comprising venezuelan equine encephalitis virus replicon vectors and paramyxovirus protein antigens |
| US7419674B2 (en) * | 2003-07-11 | 2008-09-02 | Alpha Vax, Inc. | Alpha virus-based cytomegalovirus vaccines |
-
2005
- 2005-05-20 CA CA2567446A patent/CA2567446C/en not_active Expired - Lifetime
- 2005-05-20 JP JP2007527564A patent/JP4896021B2/ja not_active Expired - Lifetime
- 2005-05-20 ES ES14189933.6T patent/ES2647491T3/es not_active Expired - Lifetime
- 2005-05-20 US US11/597,347 patent/US20090104226A1/en not_active Abandoned
- 2005-05-20 WO PCT/US2005/018225 patent/WO2006078294A2/en not_active Ceased
- 2005-05-20 EP EP14189933.6A patent/EP2848692B1/en not_active Expired - Lifetime
- 2005-05-20 EP EP14160481.9A patent/EP2811027A1/en not_active Withdrawn
- 2005-05-20 EP EP05856754.6A patent/EP1766034B1/en not_active Expired - Lifetime
-
2008
- 2008-05-12 JP JP2008125258A patent/JP2008266341A/ja active Pending
-
2010
- 2010-06-01 US US12/791,140 patent/US20110002958A1/en not_active Abandoned
-
2014
- 2014-08-20 US US14/463,831 patent/US9730997B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008500399A5 (enExample) | ||
| US20240075125A1 (en) | Expression systems | |
| Denis et al. | Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform | |
| Levi et al. | Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection | |
| NO20063157L (no) | Influensa-immunogen og vaksine | |
| NO20082149L (no) | Hundeinfluensavirus og relaterte sammensetninger og fremgangsmater for bruk | |
| JP2013518052A5 (enExample) | ||
| WO2014205579A4 (en) | Modified matrix proteins of vesicular stomatitis virus | |
| ATE419369T1 (de) | Chimäre mensch-rinder respiratory syncytial virus vakzinen | |
| JP2014507146A5 (enExample) | ||
| BR0312173A (pt) | Mólecula de cdna, molécula e sequência de cdna recombinante, vetor, processo de preparação de partìculas de vìrus do sarampo infeccioso, composição imunogênica, composição de vacina e vìrus mononegaviral recombinante | |
| WO2019092002A1 (en) | Pharmaceutical compositions for treatment or prevention of viral infections | |
| CA2835967A1 (en) | Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response | |
| CN101899461B (zh) | 一种编码甲型流感病毒NP蛋白和M2e多肽的融合基因 | |
| Tomčíková et al. | Different mechanisms of the protection against influenza A infection mediated by broadly reactive HA2-specific antibodies | |
| US20160120974A1 (en) | Semi-live respiratory syncytial virus vaccine | |
| CN107961371A (zh) | 季节流感-rsv联合疫苗及其制备方法和应用 | |
| Hnuma et al. | Characteristics of Cytotoxic T Lymphocytes Directed to Influenza Virus Haemagglutinin Elicited by Immunization with Muramyldipeptide‐Influenza Liposome Vaccine | |
| US20160346378A1 (en) | Semi-live respiratory syncytial virus vaccine | |
| JP7651129B2 (ja) | ウイルスの非構造タンパク質が担持された複合タンパク質単量体、当該単量体の会合体、及び当該会合体を有効成分とするコンポーネントワクチン | |
| Dehari et al. | RNA-Based Vaccines for Infectious Disease | |
| KR20240011134A (ko) | Rsv 및 piv3 감염을 예방하기 위한 조성물 및 방법 | |
| HUT54732A (en) | Process for producing vaccine polypeptides | |
| CN102174090B (zh) | 一种猪源a型流感病毒头部蛋白及其制备方法和应用 | |
| WO2012053856A3 (ko) | 호흡기 신시치아 바이러스 백신 조성물 및 그의 제조방법 |